CBG in cannabis is effective in treating the spread of brain cancer.
Preliminary studies of CBG have found that cannabinoids.
Which CBG is the active ingredient, are effective in slowing the progression of glioblastoma, the most aggressive and malignant type of brain tumor (brain cancer).
The cannabinoid cannabigerol, or cannabinoid CBG, was discover by researchers in Slovenia to effective in slowing the progression of glioblastoma. The most aggressive and malignant type of primary brain tumor (brain cancer), in a cell culture study publish. This month in the online journal Cells. The research was funded by Australian company MGC Pharmaceuticals and conducted through the University Medical Centre Ljubljana, Department of Neurosurgery. Overall survival was measured at 16 months after glioblastoma diagnosis.
The researchers found that CBD and CBG, both alone and in combination. Inhibited the spread of glioblastoma cells, while the combination of CBG and THC “reduced the survival of both cell types to a similar extent.” The researchers also found that the combination of CBD and CBG was “more effective than THC,” adding that CBG and CBD “inhibited glioblastoma tumor invasion in a similar manner”
To temozolomide (the current standard-of-care chemotherapy for treating brain tumors after surgery).
“This is the first report showing. That the non-intoxicating, psychoactive cannabinoid CBG alone and in combination with CBD effectively target two key components that prevent successful treatment of glioblastoma (GBM) patients with current therapies: first, to overcome resistance [glioblastoma stem cells] to cytotoxic agents and induce apoptosis, and second, to inhibit GBM cell invasion.” Cannabigerol (CBG) is a potential novel combination therapy for glioblastoma (brain cancer), from the biology journal Cells, Feb. 5, 2021, Cells, Feb. 5, 2021
The researchers also found that CBG เล่น UFABET ผ่านมือถือ สะดวกทุกที่ ทุกเวลา was more effective at inhibiting glioblastoma cells than the chemotherapy drug temozolomide. Inhibiting 90 percent of cell lines compare to 50 percent inhibited by chemotherapy. However, the CBG elimination method reduced the effectiveness of the cell lines by 50 percent. While temozolomide was effective in 40 percent to 60 percent of the cell lines.